Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biological Therapy of Severe Asthma and Nasal Polyps
Agamemnon Bakakos, Florence Schleich, Petros Bakakos
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 976-976
Open Access | Times Cited: 24

Showing 24 citing articles:

Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis
Corrado Pelaia, Giulia Pelaia, Angelantonio Maglio, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3371-3371
Open Access | Times Cited: 27
Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient
Linda Rogers, Miloš Jeseňák, Leif Bjermer, et al.
Respiratory Medicine (2023) Vol. 218, pp. 107414-107414
Open Access | Times Cited: 25
Eosinophil-Driven vs. Eosinophil-Associated Severe Asthma: Practical Implications for Target Treatment
Valentina D’Aiuto, Ilaria Mormile, Francescopaolo Granata, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1729-1729
Open Access
Roles of type 1 regulatory T (Tr1) cells in allergen-specific immunotherapy
Masaya Matsuda, Tetsuya Terada, Kazuyuki Kitatani, et al.
Frontiers in Allergy (2022) Vol. 3
Open Access | Times Cited: 16
Comorbid asthma in patients with chronic rhinosinusitis with nasal polyps: did dupilumab make a difference?
Mona Al‐Ahmad, Asmaa Ali, Mustafa Ali Khalaf, et al.
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Epidemiology and Immunopathogenesis of Virus Associated Asthma Exacerbations
Agamemnon Bakakos, Zoi Sotiropoulou, Angelos Vontetsianos, et al.
Journal of Asthma and Allergy (2023) Vol. Volume 16, pp. 1025-1040
Open Access | Times Cited: 8
Therapeutic Strategies to Prevent the Recurrence of Nasal Polyps after Surgical Treatment: An Update and In Vitro Study on Growth Inhibition of Fibroblasts
Angela Rizzi, Luca Gammeri, Raffaele Cordiano, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 8, pp. 2841-2841
Open Access | Times Cited: 7
Clinical Effects and Response Time of Biological Drugs in Chronic Rhinosinusitis with Nasal Polyps Patients: Real‐life Experience
S. De Santis, Stefania Galassi, Jacopo Cambi
The Laryngoscope (2024)
Closed Access | Times Cited: 2
Baseline Characteristics of Patients Enrolled in Clinical Trials of Biologics for Severe Asthma as Potential Predictors of Outcomes
Francesco Menzella
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1546-1546
Open Access | Times Cited: 6
Bronchial Asthma as a Cardiovascular Risk Factor: A Prospective Observational Study
Marcela Kreslová, Olga Kirchnerová, Daniel Rajdl, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2614-2614
Open Access | Times Cited: 9
Comparison between clinical trials and real-world evidence studies on biologics for severe asthma
Francesco Menzella, Andrea Ballarin, Maria Cristina Sartor, et al.
Journal of International Medical Research (2022) Vol. 50, Iss. 11
Open Access | Times Cited: 9
Advances in Sinus Surgery for Nasal Polyps
T. Graham Norwood, Jessica W. Grayson, Bradford A. Woodworth
American Journal of Rhinology and Allergy (2023) Vol. 37, Iss. 2, pp. 162-167
Closed Access | Times Cited: 4
Allergy and Asthma Prevalence and Management Across Nasal Polyp Subtypes
Kody G. Bolk, Thomas S. Edwards, Sarah K. Wise, et al.
Otolaryngologic Clinics of North America (2023) Vol. 57, Iss. 2, pp. 253-263
Closed Access | Times Cited: 4
Do Comorbidities Influence the Response to Biologics in Severe Asthma?
Corrado Pelaia, Girolamo Pelaia, William W. Busse
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 209, Iss. 3, pp. 233-235
Open Access | Times Cited: 4
The role of radiological imaging in the management of severe and difficult-to-treat asthma
Joshua Aigbirior, A Almaghrabi, Monder Lafi, et al.
Breathe (2024) Vol. 20, Iss. 2, pp. 240033-240033
Open Access | Times Cited: 1
Immunobiological therapy in the treatment of severe asthma
David Evangelista Barros de Oliveira, Carlos Gustavo Alves Leitão, F Falcão, et al.
Research Society and Development (2024) Vol. 13, Iss. 5, pp. e14513545933-e14513545933
Open Access
Dupilumab treatment for severe chronic rhinosinusitis with nasal polyps: efficacy and impact on co-existing mild to moderate asthma
Niki Papapostolou, Michaël Makris
(2024), pp. 186-194
Open Access
Outcomes of biological therapy in patients with severe asthma with chronic rhinosinusitis in Saudi Arabia: patients with nasal polyps versus those without nasal polyps
Usama E. Abu Elhassan, Medhat Elnamaky, Abdulaziz Alfifi, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access
Impact of biological therapies on laboratory outcomes and FEV1 in patients with severe eosinophilic asthma with chronic rhinosinusitis: a real-life study from Saudi Arabia
Usama Abu Elhassan, Salihah Y. Al-Mani, Saad M. Alqahtani, et al.
Multidisciplinary Respiratory Medicine (2024) Vol. 19, Iss. Vol. 19 (2024)
Open Access
Impact of biological therapies on clinical outcomes in patients with severe eosinophilic asthma with chronic rhinosinusitis: an observational study from Saudi Arabia
Usama E. Abuelhassan, Abdelrahman M. Abdalla, Abdulaziz Alfaifi, et al.
Egyptian Journal of Bronchology (2024) Vol. 18, Iss. 1
Open Access
An interpretable cluster-based logistic regression model, with application to the characterization of response to therapy in severe eosinophilic asthma
Massimo Bilancia, Andrea Nigri, Barbara Cafarelli, et al.
The International Journal of Biostatistics (2024)
Closed Access
Asthma: From Phenotypes to Personalized Medicine
Petros Bakakos
Journal of Personalized Medicine (2022) Vol. 12, Iss. 11, pp. 1853-1853
Open Access | Times Cited: 2
Dupilumab in complex therapy for chronic rhinosinusitis with nasal polyps and asthma
D. A. Sivokhin, Е. С. Щенникова, V. V. Royuk, et al.
Meditsinskiy sovet = Medical Council (2023), Iss. 7, pp. 203-208
Open Access
Modern Approaches to the Treatment of Chronic Polypous Rhinosinusitis
Е.В. Безрукова, Ю.В. Сухарева, Р.Ф. Галеев
Оториноларингология Восточная Европа (2023), Iss. 2, pp. 171-179
Open Access
Page 1

Scroll to top